For those with HER2-positive cancer, the adjusted hazard ratio for achieving a pCR was 1.65 (95% OR 0.70–3.88, p = 0.25) for those in the highest tertile of selenium compared to those in the baseline (reference) tertile. This evidence concerns the gene ERBB2 and cancer.